Clincosm LogoSign in Get a demo

hcc

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HCC, Liver Cirrhosis Trial (sequential adult left lateral lobe liver transplantation (SALT))

Not yet recruiting
  • HCC
  • Liver Cirrhosis
  • sequential adult left lateral lobe liver transplantation (SALT)
  • (no location specified)
Oct 3, 2023

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023

A New Conception About Individualized Treatment Allocation for

Completed
  • HCC
  • +2 more
  • TACE
  • (no location specified)
Aug 22, 2023

HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated

Not yet recruiting
  • HBV
  • HCC
  • nucleoside analogues or interferon
  • Hefei, Anhui, China
  • +9 more
Jul 20, 2023

HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

Not yet recruiting
  • HCC
  • Zabadinostat (CXD101) and Geptanolimab
  • Lenvatinib and Sorafenib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 15, 2023

Long Non-coding RNA SNHG15 asNovel Biomarker in HBV Associated

Not yet recruiting
  • HCC
  • No intervention was required for patients or control group in this study
  • (no location specified)
Apr 21, 2023

Study of Serum Tumor Markers of HBV Associated HCC

Not yet recruiting
  • HCC
  • tumor tissue and blood tests
  • (no location specified)
Apr 10, 2023

HCC Trial in China (DEB-TACE and HAIC, DEB-TACE)

Recruiting
  • HCC
  • DEB-TACE and HAIC
  • DEB-TACE
  • Luohe, Henan, China
  • +15 more
Mar 28, 2023

Early Diagnosis of Hepatocellular Carcinoma (HCC)

Recruiting
  • HCC
  • +4 more
  • Biomarker dosage
  • Castellana Grotte, Bari, Italy
    RCCS "Saverio de Bellis"
Mar 23, 2023

Locally Advanced or Metastatic Solid Tumors, NSCLC, HNSCC Trial in Australia, United States (RO7502175, Atezolizumab)

Recruiting
  • Locally Advanced or Metastatic Solid Tumors
  • +10 more
  • Aurora, Colorado
  • +6 more
Jan 4, 2023

Liver Tumor, HCC, Metastasis Trial in United States (HistoSonics Histotripsy)

Recruiting
  • Liver Tumor
  • +2 more
  • HistoSonics Histotripsy
  • Miami, Florida
  • +7 more
Jan 3, 2023

Artificial Intelligence and Hepatocellular Carcinoma

Active, not recruiting
  • HCC
  • CT Scan Radiomics Features Extraction
  • Rozzano, Lombardy, Italy
    IRCCS Istituto Clinico Humanitas
Dec 1, 2022

HCC Trial in Hong Kong (procedure, radiation, drug)

Active, not recruiting
  • HCC
  • TACE
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Oct 24, 2022

HCC Trial in Pisa (Microwave ablation + Occlusafe + DEB-TACE, Microwave ablation + Occlusafe, Microwave ablation + DEB-TACE)

Recruiting
  • HCC
  • Microwave ablation + Occlusafe + DEB-TACE
  • +2 more
  • Pisa, Italy
    Azienda Ospedaliero-Universitaria Pisana
Oct 21, 2022

Liver Tumor, HCC, Metastasis Trial in Worldwide (HistoSonics Histotripsy)

Recruiting
  • Liver Tumor
  • +2 more
  • HistoSonics Histotripsy
  • Braunschweig, Germany
  • +5 more
Oct 13, 2022

Hepatocellular Carcinoma, Peritoneal Metastasis, Hyperthymic Trial in Chengdu (mitomycin C-based hyperthermic intraperitoneal

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • mitomycin C-based hyperthermic intraperitoneal chemotherapy
  • Chengdu, Sichuan, China
    West China Hospital
Sep 14, 2022

Solid Tumor, Cancer, Carcinoma Trial in United States (Mogamulizumab + Nivolumab)

Completed
Has Results
  • Solid Tumor
  • +4 more
  • Mogamulizumab + Nivolumab
  • Gilbert, Arizona
  • +14 more
Jul 27, 2022

Multi-analyte Blood Test Clinical Trial

Recruiting
  • Liver Cirrhosis
  • +3 more
  • Multi-analyte Blood Test
  • Mission Hills, California
  • +6 more
Aug 16, 2022

Severity of Liver Disease and Development of HCC in Cirrhotic

Not yet recruiting
  • HCC
    • (no location specified)
    Jul 22, 2022

    Hepatocellular Carcinoma, HCC, Liver Cancer Trial in Hong Kong (Nivolumab, Hepatectomy)

    Completed
    • Hepatocellular Carcinoma
    • +2 more
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Jul 20, 2022

    HCC, NSCLC Stage IIIB, NSCLC Stage IV Trial in Worldwide (YH001 + Toripalimab)

    Not yet recruiting
    • HCC
    • +2 more
    • YH001 + Toripalimab
    • Canton, Ohio, Armenia
    • +21 more
    Jul 20, 2022

    MRD Recurrence Monitoring After Surgical Resection of

    Not yet recruiting
    • HCC
    • Liver resection
    • (no location specified)
    Jul 10, 2022

    A Novel MSE Score to Predict rHCC Patients

    Completed
    • HCC
    • hepatectomy
    • (no location specified)
    Jul 8, 2022

    HCC Trial in Hong Kong, Seoul (Cabozantinib)

    Active, not recruiting
    • HCC
    • Hong Kong, Hong Kong
    • +1 more
    Jun 27, 2022

    Advanced Solid Tumor, Lymphoma, NSCLC Trial in Chaoyang, Cangzhou, Tianjin (BPI-371153)

    Not yet recruiting
    • Advanced Solid Tumor
    • +3 more
    • Chaoyang, Beijing, China
    • +3 more
    Jun 15, 2022